Fisher & Paykel Healthcare logo

FPH - Fisher & Paykel Healthcare News Story

NZD33.51 -0.4  -1.2%

Last Trade - 3:50am

Large Cap
Market Cap £10.17bn
Enterprise Value £10.14bn
Revenue £834.4m
Position in Universe 30th / 1907

UPDATE 1-NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

Tue 12th December, 2017 2:11am
(Adds background, shares movement) 
    Dec 12 (Reuters) - New Zealand's Fisher & Paykel Healthcare 
 FPH.NZ  filed a lawsuit in Australia on Tuesday against Resmed 
Inc  RMD.N  alleging the medical device manufacturer's 
respiratory treatment products violate four Fisher & Paykel 
    Fisher & Paykel said it was seeking a range of legal 
remedies from the lawsuit, including banning the manufacture and 
sale of such Resmed products in Australia. 
    The company added its earnings forecast for fiscal 2018 
remained unchanged. 
    Fisher & Paykel and California-based Resmed are engaged in 
patent disputes in several countries over medical devices used 
to treat respiratory conditions.  
    Fisher & Paykel had filed a case against Resmed in Britain 
in 2016 and said last month it could continue to sell its sleep 
apnea masks in the country after a UK court ruled Resmed's 
patent was invalid.*:nL3N1NI0H4 
    Resmed was not immediately available for a comment. 
    Fisher & Paykel shares were about 1 percent lower after the 
announcement, in a lower overall market in New Zealand. Resmed's 
Australia shares  RMD.AX  were down about 1 percent while the 
larger Australian market traded flat. 
 (Reporting by Christina Martin in Bengaluru; Editing by Stephen 
Coates and Sam Holmes) 
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.